Adagene ADAG
NASDAQ ADAG
$3.58 -0.11 (-2.98%)
As of: Sep 4, 2026 · 3:59 PM EDT

Adagene (ADAG) Notes Payables (2019 - 2026)

Adagene (ADAG) posted quarterly Notes Payables of $4268.2 billion for Q4 2025, down 12.34% year-over-year from $4869.0 billion in Q4 2024, and up 203693259.97% quarter-over-quarter from $2.1 million in Q2 2025.

Analysis

Adagene (ADAG) Notes Payables (2019 - 2026) Analysis & Trends

Adagene (ADAG) has reported Notes Payables for 7 consecutive years, with $4268.2 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Notes Payables fell 12.34% year-over-year to $4268.2 billion; the TTM figure through Dec 2025 stood at $4268.2 billion (down 12.34% YoY), while the FY2025 annual figure was $4268.2 billion, down 12.34% from the prior year.
  • Notes Payables climbed to $4268.2 billion in Q4 2025 per ADAG's latest filing, from $2.1 million in the prior quarter.
  • Across five years, Notes Payables topped out at $10768.7 billion in Q4 2022 and bottomed at $2.1 million in Q2 2025.
  • Historically, Notes Payables has averaged $3909.7 billion across 5 years, with a median of $4251.9 billion in 2023.
  • Annual changes were most pronounced in 2022 — Notes Payables surged 345016409.54% — and 2024, when it plunged 100.0%.
  • Adagene's Notes Payables stood at $3.1 million in 2021, then soared by 345016409.54% to $10768.7 billion in 2022, then slumped by 60.67% to $4235.7 billion in 2023, then increased by 14.95% to $4869.0 billion in 2024, then declined by 12.34% to $4268.2 billion in 2025.
  • Business Quant data shows ADAG's Notes Payables at $4268.2 billion in Q4 2025, $2.1 million in Q2 2025, and $4869.0 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Adagene 211.24 Mn 211.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.40 Mn
Dec 31, 2025 4.27 Mn
Jun 30, 2025 2.10 Mn
Dec 31, 2024 4.87 Mn
Jun 30, 2024 4.21 Mn
Dec 31, 2023 4.24 Mn
Jun 30, 2023 9.00 Mn
Dec 31, 2022 10.77 Mn
Jun 30, 2022 5.96 Mn
Dec 31, 2021 3.12 Mn
Jun 30, 2021 3.85 Mn
Dec 31, 2020 3.83 Mn
Dec 31, 2019 716,723.00